The newest human papillomavirus vaccine can potentially prevent 80% of cervical cancers in the United States if given to all 11- or 12-year-old children before they are exposed to the virus, according a study published in the Journal of the National Cancer Institute and conducted by The Centers for Disease Control and Prevention and Cedars-Sinai.